Wellinks

Summary active Updated Aug 6, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location New Haven, CT
Founded 2016
Latest Stage Series B
Total Raised ~$10M+ (Series B first close)

About

Wellinks is a New Haven, Connecticut-based cardiopulmonary care company that combines virtual chronic disease management with remote patient monitoring through its FDA-cleared Spire Remote Patient Monitoring (RPM) System 12. The platform uses proprietary Health Tags for passive monitoring aimed at identifying early physiologic changes associated with clinical deterioration — targeting detection roughly a week before symptom onset in patients with chronic respiratory disease 12. On 2026-08-04 Wellinks announced the first close of a $10M Series B led by UMass Memorial Health alongside inside investors, building on a multiyear commercial relationship 13.

Funding History

Date Round Amount Lead Co-investors
2026-08-04 Series B (first close) $10M UMass Memorial Health Existing inside investors 123

What Investors Say

“Our continued collaboration with Wellinks reflects a shared commitment to advancing proactive, data-driven care. Together, we’re generating real-world clinical evidence that supports better outcomes for patients and informs the future of cardiopulmonary care.” — Dr. Eric Dickson, CEO, UMass Memorial Health 1

What Founders Say

“This investment represents validation of the solution we’ve built and the outcomes it delivers.” — Jennifer Barretta, COO and Interim CEO, Wellinks 1

Sources


  1. PR Newswire, “Wellinks Closed $10 Million Series B Funding from UMass Memorial Health and inside investors,” August 4, 2026. Accessed August 2026. https://www.prnewswire.com/news-releases/wellinks-closed-10-million-series-b-funding-from-umass-memorial-health-and-inside-investors-302842712.html

  2. HIT Consultant, “Wellinks Raises $10M to Scale Predictive Cardiopulmonary RPM,” August 5, 2026. Accessed August 2026. https://hitconsultant.net/2026/08/05/wellinks-secures-10m-series-b-funding-predictive-cardiopulmonary-rpm/

  3. Medical Device Network, “Wellinks secures $10m for respiratory disease RPM tool’s advancement,” August 2026. Accessed August 2026. https://www.medicaldevice-network.com/news/wellinks-secures-10m-for-respiratory-disease-rpm-tool-advancement/